Results 281 to 290 of about 443,008 (348)

Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Pixner T, Chaikouskaya T, Lauth W, Zimmermann G, Mörwald K, Lischka J, Furthner D, Awender E, Geiersberger S, Maruszczak K, Forslund A, Anderwald CH, Cadamuro J, Weghuber D, Bergsten P.   +14 more
europepmc   +1 more source

Gut Health in Ostriches (Struthio camelus): Insights Into Intestinal Structure, Functions, Microbiome, and Improvement Strategies

Animal Research and One Health, EarlyView.
Our paper systematically reviews the intestinal structure, function, and microbiota of ostriches, along with strategies for improving their gut health. We analyze how these factors collectively influence intestinal homeostasis and ostrich welfare, emphasizing probiotics as a promising intervention to enhance gut health, boost population well‐being, and
Zi‐Qun Zhang, Fang‐Fang Guo, Wen‐Juan Du, Meng Li, Aftab Shaukat, Zhu‐Qing Jia, Shu‐Cheng Huang   +6 more
wiley   +1 more source

Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. [PDF]

J Investig Med
Abushamat LA, Schauer IE, Low Wang CC, Mitchell S, Herlache L, Bridenstine M, Durbin R, Snell-Bergeon JK, Regensteiner JG, Reusch JE.   +9 more
europepmc   +1 more source

Didymin protects pancreatic beta cells by enhancing mitochondrial function in high-fat diet-induced impaired glucose tolerance. [PDF]

Diabetol Metab Syndr
Yang J, Zou Y, Lv X, Chen J, Cui C, Song J, Yang M, Hu H, Gao J, Xia L, Wang L, Chen L, Hou X.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Lancet, The, 2006
rosiglitazone Medication Trial Investigators, Theodora S Temelkova-Kurktschiev, H. Gerstein, S. Yusuf, J. Bosch, J. Pogue, P. Sheridan, N. Dinççağ, M. Hanefeld, B. Hoogwerf, M. Laakso, V. Mohan, J. Shaw, B. Zinman, R. Holman   +14 more
semanticscholar   +3 more sources

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.

Lancet, The, 2014
T. Yates, Steven M Haff, P. Schulte, L. Thomas, Kim M Huff man, C. Bales, R. Califf, R. Holman, J. McMurray, A. Bethel, J. Tuomilehto, M. Davies, W. Kraus   +12 more
semanticscholar   +3 more sources

Impaired Glucose Tolerance

Encyclopedia of Behavioral Medicine, 2020
B. Mullan
openaire   +2 more sources

Impaired Glucose Tolerance and Neuropathy

The Neurologist, 2008
Peripheral neuropathy is common. Diabetes is the most common cause, accounting for approximately half of cases, but up to 1/3rd of neuropathy patients have no identifiable etiology. Among this population, impaired glucose tolerance (IGT or "prediabetes") is observed in approximately 40%.
A Gordon, Smith, J Robinson, Singleton
openaire   +2 more sources